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Abstract
Purpose: Prospective surveillance of invasive mold diseases (IMDs) in haematology patients should be standard of care but
is hampered by the absence of a reliable laboratory prompt and the difficulty of manual surveillance. We used a high
throughput technology, natural language processing (NLP), to develop a classifier based on machine learning techniques to
screen computed tomography (CT) reports supportive for IMDs.
Patients and Methods:We conducted a retrospective case-control study of CT reports from the clinical encounter and up to
12-weeks after, from a random subset of 79 of 270 case patients with 33 probable/proven IMDs by international definitions,
and 68 of 257 uninfected-control patients identified from 3 tertiary haematology centres. The classifier was trained and
tested on a reference standard of 449 physician annotated reports including a development subset (n = 366), from a total of
1880 reports, using 10-fold cross validation, comparing binary and probabilistic predictions to the reference standard to
generate sensitivity, specificity and area under the receiver-operating-curve (ROC).
Results: For the development subset, sensitivity/specificity was 91% (95%CI 86% to 94%)/79% (95%CI 71% to 84%) and ROC
area was 0.92 (95%CI 89% to 94%). Of 25 (5.6%) missed notifications, only 4 (0.9%) reports were regarded as clinically
significant.
Conclusion: CT reports are a readily available and timely resource that may be exploited by NLP to facilitate continuous
prospective IMD surveillance with translational benefits beyond surveillance alone.
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Introduction
Despite the high health and economic burden [1] of invasive
mold diseases (IMDs) and effort invested in preventing them,
prospective continuous epidemiological surveillance as advocated
by professional societies and practice guidelines [2–4] is rarely
performed. Prospective epidemiological surveillance in routine
practice [5] is an onerous and costly task for hospitals principally
because IMDs lack an easily identifiable and consistent laboratory
prompt such as a positive blood culture. Case finding, like
diagnosis, relies on a constellation of findings from clinical review
in conjunction with radiology and microbiology with adjudication
by experts using complicated case definitions [6] making it a time-
consuming and therefore costly exercise that is not widely
performed outside research protocols [7–10].
For surveillance in general, the primary screening method
should have a high sensitivity in order to minimise the burden of
case finding while maximising case capture. However, for
epidemiological surveillance of IMDs the ideal screening method
is undefined. Laboratory-based surveillance is subject to significant
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underreporting because IMDs may be diagnosed with or without
microbiological confirmation corresponding to probable/proven
and possible categories respectively [6]. Indeed possible infections
may predominate in some settings [11–13] due to the difficulties in
establishing a microbiological diagnosis given that conventional
microbiology for Aspergillus and hyaline molds is positive in 50%
or fewer of cases [14] and patient acuity often contraindicates
invasive diagnostic procedures. Microbiological confirmation is
further hampered by the fact that non-culture based tests (NCBTs)
such as galactomannan (GM) or polymerase chain reaction (PCR)
are not widely available and have a suboptimal sensitivity [15,16]
which is further compromised by concomitant antifungal therapy
administered for either treatment or prophylaxis [17]. Adminis-
trative data such as coding diagnoses is unreliable for IMD
surveillance [18] and neither timely nor informative enough for
outbreak detection. In practice, no single method will be adequate
for epidemiological surveillance of IMDs and complete case
capture will require, the pooling of data from multiple sources
[7,8,18]. However, the combination of laboratory based data with
clinical or bed-side surveillance to best characterize total disease
burden is not feasible for many centers to perform in real-time as it
is a labour and time intensive task.
Although the optimal screening method for epidemiological
surveillance of IMDs is undefined, the high frequency of
pulmonary involvement makes chest computed tomography
(CT) imaging an attractive target for screening. Chest CT is
routinely performed when IMD is suspected as it is a non-invasive
test that is widely available with results reported within hours
rather than days and pulmonary involvement is present in 90% to
100% of patients with IA [7,8,10]. Although lung sampling and
other laboratory indicators could be used for epidemiological
surveillance and may upgrade possible cases to probable/proven
categories they are not performed with the same frequency of CT.
The major shortcomings of CT, however, are its poor specificity
for IMDs [19] and extracting meaning from free-text reports.
We hypothesized that epidemiological surveillance of IMDs that
is cost-effective and sustainable could be facilitated by technology.
Natural language processing (NLP) is a computational method of
analyzing human language that has detected several medical
conditions [20–24] from the wealth of unstructured data in
hospitals, with an accuracy comparable to human interpretation
[24–26]. We developed a classifier that uses NLP based on
machine learning techniques, to flag suspicious CT reports
performed during routine clinical practice as a means of
facilitating prospective IMD epidemiological surveillance in
hospitals.
Methods
Study Design and Setting
This was a retrospective case-control cohort study of patients
from three tertiary adult university-affiliated hospitals (Alfred
Health, AH; Peter MacCallum Cancer Institute, PM; Royal
Melbourne Hospital, RMH). AH and RMH operate statewide
haematopoietic stem cell transplant (HSCT) services which
collectively perform approximately100 allogeneic transplants/
year. De-identified patient records were used and the human
research ethics committees at each site who granted permission for
the study, waived patient consent.
Inclusion and Exclusion Criteria
Case and uninfected control patients from 2003 to 2011
inclusive were identified from previously completed clinical
mycology studies [1,12,27,28] (Ananda-Rajah et. al. Unpublished
work: Prophylactic Effectiveness & Safety Of Intermittent Lipo-
somal Amphotericin In High Risk Haematological Patients
Abstract no M-280 51st Interscience Conference on Antimicrobial
Agents and Chemotherapy ASM, Chicago 2011) pharmacy
dispensing records, antimicrobial stewardship, HSCT, infectious
diseases databases and microbiology records. Patients lacking CT
scan reports were excluded, as were exclusively brain scans in
order to focus detection of sino-pulmonary disease. Because
detection of IMDs was the intent, patients with isolated
candidaemia were excluded as laboratory-based surveillance is
suitable for this infection.
Clinical Data and Definitions
CT reports from haematology/HSCT patients with (i.e. cases)
and without IMDs (i.e. controls) were manually downloaded from
each hospital as de-identified text files. CT reports, from
performance of the diagnostic scan and for 12 weeks thereafter
(in order to evaluate radiological progression) performed during
the clinical encounter were included. The clinical encounter was
defined from admission to either discharge, death or transfer.
Clinical information was extracted from aforementioned study
datasets and hospital records. IMDs were classified according to
consensus definitions by expert reviewers [6]. Date of diagnosis
was defined as the first day of suspicious radiological abnormality
for possible cases or for probable/proven cases, a positive
microbiological or histopathological test.
Development of the Reference Standard
A randomly selected convenience subset of reports from case
and control patients were annotated at sentence and scan level by
three infectious diseases physicians (MAR, KT, MS). The primary
reviewer (MAR) annotated all case and control reports. Secondary
review of case reports was undertaken by two physicians (KT,
MS). The secondary reviewers served to validate the primary
reviewer’s analysis through measures of agreement. Pre-specified
annotation guidelines were refined with differences in opinion
resolved by discussion at face-to-face meetings. An iterative
process of annotation ensued with reports from case patients
annotated twice or three times over, while those from control
patients (from the outset regarded as less challenging to interpret)
were annotated once by the primary reviewer (MAR).
For annotation, each sentence within a report and each report
was treated as an independent observation, meaning that for
sentence level annotation, sentences rather than specific words
were coded according to the following contextual features:
specificity for IMD (specific vs non-specific features e.g. macro-
nodules, halo vs. infiltrates, ground-glass, consolidation); certainty
(suggestive, equivocal or not supportive of IMD), directionality/
change (negation, stable, resolution, progression); temporality
(recent, past); alternative processes (e.g. pulmonary emboli, edema)
and clinical alerts (i.e. urgent follow-up required). Scan level
annotation referred to classification of the entire report as being
either supportive or not for IMD with equivocal scans subse-
quently merged with supportive reports. Supportive reports had
specific features of IMD including halo, nodule, cavity, focal mass,
wedge-shaped lesions, bony sinus erosions. Negative reports had
none of the above features while equivocal reports included
infiltrate, consolidation, ground glass change, effusions or uncer-
tainty by the reporting radiologist.
Importantly, the reference standard was informed by the
opinion of clinician experts rather than radiologists given that
the guiding principle was to flag reports of concern to end-users
irrespective of the final diagnostic outcome.
Automated Surveillance of Mold Infections
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Development of the Classifier
Reports were classified in a binary fashion as being supportive
or not supportive of IMD (i.e. positive/negative). A multi-class
classification approach at sentence level was used: each sentence
allocated one of a number of classes, with all sentence-level
classifications subsequently informing the report level decision.
Text was analyzed as groups of words (‘‘bag-of-words’’), phrases
(‘‘bag-of-phrases’’) and concepts (‘‘bag-of-concepts’’) [29] which
were extracted from the annotated reports. The bag-of-words
framework collates unordered sets of words, mapping dates and
numbers to date and number features respectively. The bag-of-
phrases framework uses phrases identified by MetaMap [29]
corresponding to concepts from the Unified Medical Language
System (UMLS) Metathesaurus. The version of MetaMap
employed leverages the Negex tool [30] to determine negation
of a concept (e.g., ‘‘… is not consistent with …’’). The bag-of-
concepts framework used Metathesaurus concepts mapped by
MetaMap, noting that multiple phrases may map to the same
concept.
We adopted a supervised machine learning approach experi-
menting with several machine learning algorithms including
Support Vector Machines (SVM), Naı¨ve Bayes, Random Forests,
and Bayesian Nets, as implemented in the Weka 3.6.0 [31] and
LibSVM 3.11 [32] toolkits. Briefly, supervised machine learning is
a group of computational methods which use algorithms to
Table 1. Characteristics of patients with and without invasive mold diseases (IMDs).
Characteristic IMD group n (%) Control group n (%)
No. of patients 79 68
No. of clinical encounters1 79 (51) 75 (49)
Male gender 48 (61) 35 (51)
Age, mean (range) years 53 (20–89) 51 (18–89)
Underlying disease
AML 32 (41) 35 (51)
ALL 14 (18) 14 (19)
Lymphoma 15 (19) 12 (16)
Chronic leukaemia 7 (8.9) 1 (1.3)
MDS/transformed MDS 6 (7.6) 2 (2.7)
Multiple myeloma 3 (3.8) 3 (4)
Other 2 (2.5) 5 (6.7)
Neutropenia (#0.5 cells/L) present 65 (82) 56 (75)
Median duration of neutropenia (IQR), days 18 (8–45) 19 (5–39)
HSCT 36 (46) 39 (52)
Allogeneic 31/36 (86) 30/39 (77)
Autologous 5/36 (14) 9/39 (23)
Characteristics of IMDs, n = 79 NA
Probable/proven IMDs 33 (42)
Possible IMDs 46 (58)
Site of infection
Lung 67 (85)
Sino-pulmonary 3 (3.8)
Sinus 2 (2.5)
Hepatosplenic 2 (2.5)
Disseminated 4 (5.1)
Organism
Aspergillus fumigatus 13
Non-fumigatus Aspergillus species (A. niger, A. flavus) 4
Fungal hyphae resembling Aspergillus species 3
Scedosporium species 4
Any positive PCR 2
Rhizopus species 4
Other molds (Acrophialophora fusispora, Paecilomyces lilacinus) 2
Candida glabrata (co-infection with S. Prolificans fungaemia) 1
Abbreviations: AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; IQR, inter-quartile range; HSCT, haematopoietic stem
cell transplant.
1Clinical encounter defined from admission to either discharge, death or transfer and for up to 12-weeks after where applicable.
doi:10.1371/journal.pone.0107797.t001
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automatically construct a model from labeled/annotated training
data that is then used to predict classification in unseen/unlabeled
examples [33]. Of the algorithms tested, SVM performed best and
was selected for the final classifier.
Physician annotated reports were divided into development
(n = 366) and held-out sets (n = 83), the latter annotated at scan
level only. We used 10-fold cross validation on the development set
with the optimal classifier identified from experiments, tested
against the held-out set which served as an additional validation
step. Cross-validation is an accepted method within the machine
learning domain that maximizes limited gold standard data while
minimizing the risk of overfitting associated with training on the
test set [34].
Statistical Analysis
The results of each manually annotated report was compared to
the binary and probabilistic predictions of the classifier allowing
calculation of sensitivity, specificity and receiver operating curve
(ROC).
Hypothetical IMD prevalence rates of 5%, 10% and 20% were
used to estimate positive and negative predictive values (PPV,
NPV). Inter-annotator agreement was assessed using Cohen’s
kappa coefficient, a chance corrected index of agreement [35]. All
analyses used Stata 11.0 software (Stata Corp, College Station,
Texas, USA).
Results
Patient Characteristics
A total of 147 patients were included in the annotated subset of
449 reports; 79 (54%) had IMDs and 68 (46%) were control
patients (Table 1). Neutropenia (#0.56109 cells/L) was present in
82% and 75% of clinical encounters among case and control
patients respectively and was prolonged (median 18 and 19 days
respectively). A history of HSCT was present in 46% and 52% of
case and control patients, being allogeneic in 86% and 77% of
patients respectively.
IMDs were probable/proven in 33/79 (42%) and possible
infections in 46/79 (58%). Sinus and/or pulmonary disease
occurred in 91% of case-patients. IA comprised 20/33 (61%) of
microbiologically confirmed cases with rare molds including
Scedosporium and Rhizopus species identified in 10/33 (30%).
Table 2. Characteristics of the physician expert annotated and unannotated reports.
Characteristic Annotated reports n (%) Unannotated reports n (%)
No. of reports 449 1431
Held-out reports1 83 (18) NA
No. of patients total 147 380
No. of IMD patients 79 191
No. reports from IMD patients 294 (65) 905 (63)
No. reports from control patients 155 (35) 526
Chest (alone or in combination with sinus, abdo/pelvis, brain etc) 375 (84) 865 (60)
Sinus (alone or brain-sinus, orbits, abdo/pelvis) 38 (8.5) 44
Other (abdo, abdo pelvis, liver, aorta, neck) 36 (8.0) 408
No. of reports according to study site
Hospital A 226 (50) 713
Hospital B 131 (29) 422
Hospital C 92 (20) 296
No. of words per report according to study site
Hospital A 211 229
Hospital B 126 128
Hospital C 314 348
Abbreviation: IMD, invasive mold disease.
1Held out reports were annotated at scan level only as being supportive, unequivocal or negative for IMD.
doi:10.1371/journal.pone.0107797.t002
Table 3. Performance characteristics of the classifier.
Characteristic TP FP TN FN Sn, % (95%CI) Sp, % (95%CI)
Development dataset, reports n = 366 197 32 117 20 91 (86 to 94) 79 (71 to 84)
1Held-out dataset, reports n = 83 35 13 30 5 88 (74 to 95) 70 (55 to 81)
All reports, n = 449 232 45 147 25 90 (86 to 93) 77 (70 to 82)
1Held out dataset were annotated at report level only as being positive, negative or equivocal for IMD.
Abbreviations: TN, true positives; FP, false positives; TN, true negatives; FN, false negatives; Sn, sensitivity; Sp, specificity; CI, confidence interval.
doi:10.1371/journal.pone.0107797.t003
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Characteristics of the Dataset of CT Reports
Overall, 1880 reports were retrieved from 527 patients (51%
with IMDs) (Table 2). A total of 7083 sentences were annotated at
sentence level according to pre-defined contextual features. Mean
report length per hospital was 314, 211 and 126 words reflecting
inter-institutional variations in reporting styles. Hospital A
supplied 50% of annotated reports. The annotated dataset
predominantly comprised chest 375/449 (84%) and sinus scans
(alone or in combination with other sites) 28/449 (8.5%). In the
annotated subset, there were 10 reports from 5 outpatients, all of
who were control patients not subsequently diagnosed with IMD.
Inter-annotator agreement between primary reviewer and the
two secondary reviewers combined, was fair at sentence level for
distinguishing certainty from equivocal/negative labels (K = 0.64)
but improved at report level for the same classification (0.83) given
that K levels $0.75 represent excellent agreement [35].
Performance of the Classifier
Classifier performance among development and held-out sets
respectively, was as follows (Table 3): sensitivity (i.e. concordance
between classifier and physician annotation for reports supportive
of IMD) was 91% (95%CI 86% to 94%)/88% (95%CI 74% to
95%); specificity was 79% (95%CI 71% to 84%)/70% (95%CI
55% to 81%); false negative rates were 20/366 (9.2%) and 5/83
(12.5%). The area under the ROC for the development set was
0.92 (95%CI 0.89 to 0.94) and 0.90 (95%CI 0.86 to 0.93) for the
inpatient subset (n = 321) only (Figure 1). For the inpatient subset,
sensitivity was 85% (95% CI 79% to 90%) and specificity was 86%
(95% CI 81% to 93%). Using a sensitivity of 90% and specificity of
77% from the entire dataset of 449 reports at IMD prevalence’s of
5%, 10%, 20%, estimated PPVs were 17%, 30%, 49% and NPVs
were 99%, 99%, 97%.
Error Analysis
Of the 25 missed cases (false negatives), 4 (4/449, 0.9%) were
significant as shown in Figure 2. Reports from patients subse-
quently not diagnosed with IMD were disregarded (n = 10). The
remaining 15 reports from case-patients comprised 10 inpatient
reports including 6 progress reports whose antecedents were
appropriately flagged. Five scans from case patients performed
outside admission were follow up scans that provided information
on clinical progress. Among the 4 significant missed notifications,
one was a sinus scan in combination with a chest scan, the latter
being flagged appropriately.
Review of 45 false positive reports revealed several sources of
systematic error described in Table 4. Unsystematic errors were
the result of three reports inappropriately annotated negative, two
with sinus mucosal thickening and one describing ground glass
pulmonary changes with a fungal aetiology entertained by the
radiologist.
Discussion
Mold infections are not well suited to prospective detection
using manual methods of epidemiological surveillance due to the
absence of an easily identifiable electronic prompt but may be
rendered amenable to real-time detection using NLP of CT
reports. Our classifier flagged reports suggestive of IMD from a
variety of anatomic sites but overwhelmingly the sino-pulmonary
tract (92%), the site most commonly involved by IA [8,10,36],
achieving a sensitivity in the development subset, of 91% (95%CI
86% to 94%), specificity of 79% (95%CI 71% to 84%) and good
overall accuracy with an area under the ROC of 0.92 [37].
Performance of the classifier was validated two ways, by cross-
validation of development data in addition to held-out data,
importantly with both methods using unseen data and producing
similar findings (Table 3), lending robustness to the results.
For screening purposes, sensitivity is favoured over specificity
especially for uncommon events like IMDs because missed cases
are less tolerable than the resources spent following up false
notifications [23]. The 25/449 (5.6%) missed notifications
occurred at the expense of a modest number of false positive
reports (45/449, 10%). Inpatient reports took precedence over the
few outpatient reports given the higher clinical acuity of inpatients
and the remote but real risk of nosocomial acquisition, resulting in
a few missed notifications from case patients regarded as clinically
significant (0.9%). False notifications were expected as the classifier
was tuned for sensitivity, with inclusion of reports annotated
Figure 1. Receiver operating characteristic (ROC) curve for 321 inpatient reports comparing the probabilistic output of the
classifier to expert opinion. Area under the ROC curve = 0.90 (95%CI 0.86 to 0.93). Abbreviation: CI, confidence interval.
doi:10.1371/journal.pone.0107797.g001
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Table 4. Major systematic errors in the false notifications (false positives) for invasive mold diseases among computed
tomography reports by the classifier.
Reason for misinterpretation No. of reports Characteristics
Inconsequential nodules 10 ,1 cm nodules, granulomas
Abdominal scans 9 Non-specific hepatic or splenic lesions
Progress scans 9 Change in lesions rather than diagnosis the focus, therefore reports annotated negative by
experts
Non-specific pulmonary/thoracic lesion 8 Atelectasis, scarring, mediastinal neoplastic mass
Misclassification 3 Pulmonary oedema, septic emboli, pulmonary lesions consistent with graft versus host
disease
doi:10.1371/journal.pone.0107797.t004
Figure 2. Error analysis of reports annotated supportive for invasive mold disease (IMD) but missed by the classifier. Abbreviations:
CT, computed tomography.
doi:10.1371/journal.pone.0107797.g002
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equivocal included in the positive training bucket. Accordingly the
classifier, like the physician annotators, was not designed to be
conservative, assigning a positive label if there was any possibility
of IMD.
In the absence of a gold standard for IMD reporting we relied
upon peer review. Sentence level agreement between the primary
and secondary annotator pair was fair (K = 0.64) despite measures
mitigating unreliability including pre-specified guidelines, multiple
experts and repeated consultation to resolve differences [35]. Our
inter-annotator agreement is consistent with other cognitively
challenging tasks such as ascribing pneumonia [38–40] or central-
line associated blood stream infection [21] because deciding if
clinical narratives are compatible with these complex conditions is
sometimes difficult. Importantly, at report level, agreement was
excellent (K = 0.83), noting that this endpoint (i.e. report rather
than sentence level classification) is most relevant for the purpose
of real-time surveillance or clinical decision support.
Our classifier has several limitations. Its poor PPV was not
unexpected as PPV is highly conditional upon disease prevalence
and, for uncommon events like IMDs, will be low despite a high
sensitivity, as we observed [41]. High NPVs meant that a negative
result could exclude IMD with some confidence. False notifica-
tions could potentially undermine confidence in a surveillance
system and may be minimised (i.e. improving specificity) by
including adjunctive sources of data (e.g. antifungal drug
dispensing, microbiology) or by raising pre-test probability by
filtering reports [41] based on clinical context (a clinical query of
fever for example). It is possible but unlikely that changes in
clinical practice over the long observational period of the study
may have affected the radiological manifestations of IMD. The
opinion of expert physicians rather than radiologists informed
development of the classifier. However, these are the end users
whose clinical acumen we sought to emulate and for similar
syndromes such as pneumonia, albeit in chest radiograph reports,
clinicians have demonstrated comparable performance to
radiologists [25]. Annotation was unblinded, but informed by
annotation guidelines that were developed in an iterative process.
No conclusions can be drawn regarding classifier performance for
subgroups with small numbers of reports such as sinus disease or
hepatosplenic candidiasis. We confined ourselves to haematology-
oncology population as this group is at highest risk for IMD [8,42]
and thus our findings may not be generalizable to other risk
groups.
Further improvements in specificity may be achieved by
omitting progress reports given their overrepresentation among
false notifications. Experts often annotated progress reports
negative because diagnostic radiological features may not always
be re-iterated in a progress report. Non-specific pulmonary lesions
such as atelectasis or scarring could be disregarded with the
creation of handcrafted rules. Pulmonary nodules of questionable
significance are more challenging to address, as size of lesions was
not taken into account by the classifier. The development dataset
did not exclusively comprise proven/probable-IMDs (despite these
representing a higher degree of certainty) for several reasons:
possible IMDs constitute a substantial burden in clinical practice
and may predominate (up to 90%) in some centres [11,12];
possible IMDs consume similar health-care resources (e.g.
diagnostics, antifungal drugs) and their exclusion would underes-
timate true prevalence. Notably, all cases in our reference standard
including possible-IMDs underwent expert adjudication according
to international definitions [6]. Although we used a sample of
reports from the entire dataset, the narrow confidence intervals
around overall performance measures suggests that additional
reports would not have made an appreciable difference. Finally, a
dataset enriched with positive cases was used for classifier
development yielding results acceptable for subsequent human
verification but prospective validation of the classifier in the field is
required.
The classifier is not a diagnostic adjunct but rather a screening
tool designed to facilitate IMD case finding by exploiting routinely
available clinical data [5,7,10]. The classifier’s strengths include its
multi-site derivation; machine learning algorithms which unlike
rule or knowledge based systems do not require manual
programming of specific language features [43,44] and consisten-
cy, by avoiding subjective interpretations of complicated case
definitions [6].
Epidemiological surveillance for IMDs is needed for many
reasons, including antifungal stewardship [45], clinical trial design,
clinical audit, clinical registry development, intra and inter-facility
comparisons. However, it is rarely performed in routine clinical
practice, partly due to a lack of validated tools. Traditionally most
IMD surveillance has relied on microbiological/histological
diagnoses (which are not sensitive) with or without the addition
of clinical diagnoses (which lack specificity). The intention of the
classifier is to improve sensitivity i.e. case finding, with the
advantage of early detection. This classifier is an additional tool to
be used in combination with other methods to enable compre-
hensive surveillance of IMDs to be performed with minimal
additional effort.
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